Joint feature-sample selection and robust diagnosis of Parkinson's disease from MRI data
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Adeli, Ehsan | - |
dc.contributor.author | Shi, Feng | - |
dc.contributor.author | An, Le | - |
dc.contributor.author | Wee, Chong-Yaw | - |
dc.contributor.author | Wu, Guorong | - |
dc.contributor.author | Wang, Tao | - |
dc.contributor.author | Shen, Dinggang | - |
dc.date.accessioned | 2021-09-03T17:22:33Z | - |
dc.date.available | 2021-09-03T17:22:33Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2016-11 | - |
dc.identifier.issn | 1053-8119 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/86944 | - |
dc.description.abstract | Parkinson's disease (PD) is an overwhelming neurodegenerative disorder caused by deterioration of a neurotransmitter, known as dopamine. Lack of this chemical messenger impairs several brain regions and yields various motor and non-motor symptoms. Incidence of PD is predicted to double in the next two decades, which urges more research to focus on its early diagnosis and treatment. In this paper, we propose an approach to diagnose PD using magnetic resonance imaging (MRI) data. Specifically, we first introduce a joint feature-sample selection (JFSS) method for selecting an optimal subset of samples and features, to learn a reliable diagnosis model. The proposed JFSS model effectively discards poor samples and irrelevant features. As a result, the selected features play an important role in PD characterization, which will help identify the most relevant and critical imaging biomarkers for PD. Then, a robust classification framework is proposed to simultaneously de-noise the selected subset of features and samples, and learn a classification model. Our model can also de-noise testing samples based on the cleaned training data. Unlike many previous works that perform de-noising in an unsupervised manner, we perform supervised de-noising for both training and testing data, thus boosting the diagnostic accuracy. Experimental results on both synthetic and publicly available PD datasets show promising results. To evaluate the proposed method, we use the popular Parkinson's progression markers initiative (PPMI) database. Our results indicate that the proposed method can differentiate between PD and normal control (NC), and outperforms the competing methods by a relatively large margin. It is noteworthy to mention that our proposed framework can also be used for diagnosis of other brain disorders. To show this, we have also conducted experiments on the widely-used ADNI database. The obtained results indicate that our proposed method can identify the imaging biomarkers and diagnose the disease with favorable accuracies compared to the baseline methods. (C) 2016 Elsevier Inc. All rights reserved. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ACADEMIC PRESS INC ELSEVIER SCIENCE | - |
dc.subject | MATRIX COMPLETION | - |
dc.subject | PATTERN-ANALYSIS | - |
dc.subject | RED NUCLEUS | - |
dc.subject | CLASSIFICATION | - |
dc.subject | SEGMENTATION | - |
dc.subject | MACHINE | - |
dc.subject | IMAGES | - |
dc.subject | MODEL | - |
dc.subject | PROGRESSION | - |
dc.subject | BIOMARKERS | - |
dc.title | Joint feature-sample selection and robust diagnosis of Parkinson's disease from MRI data | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Shen, Dinggang | - |
dc.identifier.doi | 10.1016/j.neuroimage.2016.05.054 | - |
dc.identifier.scopusid | 2-s2.0-84979895498 | - |
dc.identifier.wosid | 000384074500018 | - |
dc.identifier.bibliographicCitation | NEUROIMAGE, v.141, pp.206 - 219 | - |
dc.relation.isPartOf | NEUROIMAGE | - |
dc.citation.title | NEUROIMAGE | - |
dc.citation.volume | 141 | - |
dc.citation.startPage | 206 | - |
dc.citation.endPage | 219 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalResearchArea | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.relation.journalWebOfScienceCategory | Neurosciences | - |
dc.relation.journalWebOfScienceCategory | Neuroimaging | - |
dc.relation.journalWebOfScienceCategory | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.subject.keywordPlus | MATRIX COMPLETION | - |
dc.subject.keywordPlus | PATTERN-ANALYSIS | - |
dc.subject.keywordPlus | RED NUCLEUS | - |
dc.subject.keywordPlus | CLASSIFICATION | - |
dc.subject.keywordPlus | SEGMENTATION | - |
dc.subject.keywordPlus | MACHINE | - |
dc.subject.keywordPlus | IMAGES | - |
dc.subject.keywordPlus | MODEL | - |
dc.subject.keywordPlus | PROGRESSION | - |
dc.subject.keywordPlus | BIOMARKERS | - |
dc.subject.keywordAuthor | Parkinson&apos | - |
dc.subject.keywordAuthor | s disease | - |
dc.subject.keywordAuthor | Diagnosis | - |
dc.subject.keywordAuthor | Sparse regression | - |
dc.subject.keywordAuthor | Joint feature-sample selection | - |
dc.subject.keywordAuthor | Matrix completion | - |
dc.subject.keywordAuthor | Robust linear discriminant analysis | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.